Tesla’s Explosive Revenue Suggests a Brighter Future
Last year Tesla Motors struggled to meet manufacturing targets for its only production car, the Model S, and it recently got hit with a negative review in the New York Times after a journalist ran out of power during a test drive (see “Tesla Blames New Delays on Production Difficulties” and “Musk-New York Times Debate Highlights Electric Cars’ Shortcomings”).
But things appear brighter now. Tesla announced today that its revenues have jumped by 500 percent and that it’s now making enough cars per week to deliver 20,000 of the vehicles by the end of this year. It also said it expects to make a small profit next quarter. Based on its gross margins, it seems that Tesla is now actually making its cars for less than it’s selling them for, rather than losing money on every one it makes, as had been the case previously. Improved productivity and lower costs for parts are helping. But when you factor in all of the company’s costs, including R&D and administration, the automaker still lost money—about $90 million.
Tesla says it now has 15,000 orders for the car, probably helped by receiving major awards and being featured on the cover of plenty of magazines. Who knows? The negative review and the dust-up that followed probably helped, too, if only to draw attention to the company.
Keep Reading
Most Popular

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.

This is the first image of the black hole at the center of our galaxy
The stunning image was made possible by linking eight existing radio observatories across the globe.

The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.